SYK and amyloidosis: Conversely, the inhibition or genetic deletion of SYK impairs this clearance mechanism, leading to exacerbated amyloid pathology and cognitive decline in 5-familial Alzheimer’s disease mutations (5xFAD) mice and SYK mice models [43].